Completed OBSERVATIONAL NCT05206240

Extracorporeal Shock Wave Therapy and Assessment Strategy Through a Novel Gait Analysis Tool for Post-stroke Spasticity

Efficacy of Extracorporeal Shock Wave Therapy and Assessment Strategy Through a Novel Gait Analysis Tool for Post-stroke Spasticity During COVID-19 Pandemic

Sponsor: Carol Davila University of Medicine and Pharmacy

Conditions Spastic Gait Spasticity, Muscle Stroke Hemorrhagic Stroke, Ischemic

Interventions Radial extracorporeal shock wave therapy and conventional physical therapy

Updated 4 times since 2022 Last updated: Feb 15, 2023 Started: Mar 1, 2021 Primary completion: Jun 1, 2022 Completion: Aug 1, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Spastic Gait and Spasticity, Muscle, this trial is completed. The trial is conducted by Carol Davila University of Medicine and Pharmacy and has accumulated 4 data snapshots since 2021. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Mar 2023 — Jul 2024 [monthly]

Completed

Status: Active Not Recruiting → Completed
Feb 2022 — Mar 2023 [monthly]

Active Not Recruiting

First recorded

Mar 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Carol Davila University of Medicine and Pharmacy

Data source: Carol Davila University of Medicine and Pharmacy

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bucharest, Romania